REGULAR ARTICLE
Normal growth despite GH, IGF-I and IGF-II deficiency

https://doi.org/10.1054/ghir.1999.0106Get rights and content

Abstract

A 6.5-year-old male with normal linear growth, despite septo-optic dysplasia, panhypopituitarism and a deficient GH/IGF axis, is presented. In addition to measuring IGF-I, IGF-II and IGFBP-3, serum IGFBP-1, -2, -4 and -5 were measured. A human osteosarcoma cell line was used to assess growth-promoting activity in the patient’s serum. The role of leptin in linear growth in this case was investigated. There was no evidence for hyperinsulinism or hyperandrogenism. GH was undetectable upon multiple stimulation. GHBP was elevated. Serum IGF-I (25 μg/l), IGF-II (194 μg/l), IGFBP-3 (0.4 mg/l), and IGFBP-5 (87 μg/l) levels were low compared to age-matched prepubertal children. Serum IGFBP-4 level was normal. Molecular size of IGF-II in the patient’s serum was normal, suggesting normal IGF-II bioavailability. Human osteosarcoma cell proliferation in response to the patient’s serum was similar to sera from age-matched normal controls. Leptin levels were markedly elevated. Osteoblast cell proliferation was not stimulated by leptin. The data demonstrate that normal growth and osteoblast cell proliferation in this patient is not mediated by GH, total IGFs, insulin, or leptin, and suggest the presence of a yet unidentified growth factor or mechanism. The case offers a detailed picture of binding proteins in a case of growth without GH. It introduces osteoblast cell proliferation as a method of assessing serum growth-promoting activity in such cases. It adds IGF-II and leptin to the list of excluded growth-promoting candidates in GH-independent growth, and further demonstrates our incomplete understanding of the phenomenon of growth.

References (8)

There are more references available in the full text version of this article.

Cited by (14)

  • Increased transactivation and impaired repression of β-catenin-mediated transcription associated with a novel SOX3 missense mutation in an X-linked hypopituitarism pedigree with modest growth failure

    2018, Molecular and Cellular Endocrinology
    Citation Excerpt :

    Similar situations have occasionally been described in patients with SOX3 involvement (Burkitt Wright et al., 2009; Woods et al., 2005). Linear growth is a multifactorial trait, influenced by the interaction of genetic, nutritional, hormonal, and environmental factors (Hathout et al., 1999; Lazar et al., 2003). To evaluate the genetic impact on the growth, we analyzed the target sequencing data of III4.

View all citing articles on Scopus
f1

Correspondence to: Subburaman Mohan, Professor of Medicine and Biochemistry, Loma Linda University, Mineral Metabolism (151), Jerry L. Pettis VA Medical Center, 11201 Benton Street, Loma Linda, CA 92357, USA. Tel: +1 909 825 7084 (ext. 2932); Fax: +1 909 796 1680; E-mail: [email protected]

View full text